Elsevier

Behavioural Brain Research

Volume 149, Issue 1, 4 February 2004, Pages 33-39
Behavioural Brain Research

Research report
Increased amphetamine-induced locomotion during inactivation of the basolateral amygdala

https://doi.org/10.1016/S0166-4328(03)00212-2Get rights and content

Abstract

At low doses, amphetamine has been shown to produce reliable increases in locomotor activity through its actions on the mesolimbic dopamine (DA) terminals in the nucleus accumbens (NAC). The basolateral amygdala (BLA) has recently been reported to have anatomical projections to the NAC, suggesting that it might serve to alter or modulate the function of the NAC. To test this hypothesis, the current experiment produced lidocaine-reversible lesions of the BLA and assessed changes in NAC function by examining alterations in locomotor activity in response to s.c. amphetamine (2 mg/kg). While BLA inactivation alone was found to have no effect on spontaneous or basal locomotor activity, it produced a significant potentiation of amphetamine-induced hyperactivity. These results suggest that BLA inactivation removes a system that inhibits the locomotor response to amphetamine. The data are, therefore, consistent with the view that the BLA may serve to modulate NAC function.

Section snippets

Subjects

Twenty-five male albino Sprague–Dawley rats (Charles River Laboratories, Wilmington, MA), weighing between 300 and 325 g, were individually housed in plastic tub cages (with paper shavings as bedding). The cages were located within a temperature-controlled (23 °C ) vivarium on a 12 h/12 h dark/light cycle (lights on at 07:00 h). Subjects had ad libitum access to food (Purina Rat Chow) and water throughout the course of the experiment. Each animal was gentled through handling for approximately 15 min

Results

Fig. 1 illustrates the range of cannula placements and confirms the BLA as the target site for the lidocaine infusions. Fig. 2 depicts the effect of inactivation of the BLA (IC lidocaine injections) on spontaneous locomotor activity. A two-way (Time×Group) ANOVA (using Time as a repeated measure) performed on the data from Fig. 2 confirmed the absence of any Group effect (F(1,17)=3.077, P>0.05), nor a Group×Time interaction (F(5,85)=0.301, P>0.05). The analysis revealed a significant effect of

Discussion

The data from the current experiment show that while a temporary lesion of the BLA had no effect on spontaneous locomotor activity, it enhanced the locomotor response to amphetamine. Other researchers have found similar results with BLA lesions differentially affecting spontaneous versus novelty- or amphetamine-induced locomotor activity. In results that parallel those of the present experiment, 6-OHDA lesions of the BLA had no effect on spontaneous locomotor activity, whereas the same lesions

Acknowledgements

Support for this study was provided by an NIDA grant DA-05041 awarded to A.E. The author would like to thank Drs. Mary Raven and Osnat Ben-Shahar for their invaluable advice and guidance, and Aaron Kornblith, Rhasson Ager, and Rick Bernardi for their assistance in the testing of subjects. Special thanks to Stephanie Richardson for her help with the histological analyses and to Dr. Wayne Brake for comments on an earlier version of this manuscript.

References (49)

  • P. Martel et al.

    Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study

    Pharmacol. Biochem. Behav.

    (1996)
  • J.H. Martin

    Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat

    Neurosci. Lett.

    (1991)
  • W.M. Meil et al.

    Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine

    Behav. Brain Res.

    (1997)
  • L.E. O’Dell et al.

    Behavioral effects of psychomotor stimulant infusions into amygdaloid nuclei

    Neuropsychopharmacology

    (1999)
  • M.E. Risner et al.

    Role of noradrenergic and dopaminergic processes in amphetamine self-administration

    Pharmacol. Biochem. Behav.

    (1976)
  • H. Simon et al.

    Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to d-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens

    Brain Res.

    (1988)
  • C.W. Stevenson et al.

    Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortex dopmaine response to stress

    Neuroscience

    (2003)
  • E.J. Tehovnik et al.

    Effective spread and time course of neural inactivation caused by lidocaine injection in monkey cerebral cortex

    J. Neurosci. Methods

    (1997)
  • J.J. Woodward et al.

    In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter

    Eur. J. Pharmacol.

    (1995)
  • W.L. Woolverton et al.

    Reinforcing properties of some local anesthetics in rhesus monkeys

    Pharmacol. Biochem. Behav.

    (1979)
  • W.L. Woolverton et al.

    Neurobiology of cocaine abuse

    Trends in Pharmacol. Sci.

    (1992)
  • C.Y. Yim et al.

    Mesolimbic dopamine projection modulates amygdala-evoked excitatory postsynaptic potentials in nucleus accumbens neurons: an in vivo study

    Brain Res.

    (1986)
  • H.L. Alderson et al.

    The effects of excitotoxic lesions of the basolateral amygdala on the acquisition of heroin-seeking behavior in rats

    Psychopharmacology

    (2000)
  • D.E. Brenneman et al.

    Effect of dietary lipid on locomotor activity and response to psychomotor stimulants

    Psychopharmacology

    (1982)
  • Cited by (15)

    • Differential and long-lasting changes in neurotransmission in the amygdala of male Wistar rats during extended amphetamine abstinence

      2022, Neuropharmacology
      Citation Excerpt :

      Even though expression of behavioral sensitization is primarily associated with dopaminergic neurotransmission in the nAc, the amygdala may play a role during the induction of sensitization (Kalivas and Alesdatter, 1993; Wolf et al., 1995). In fact, while inactivation of the BLA has no effect on basal locomotor activity, it potentiates amphetamine-induced hyperactivity (Woods and Ettenberg, 2004). Activation of the BLA, on the other hand, decreases amphetamine-induced locomotor activity (Lai and Chang, 2019).

    • Differential implication of dorsolateral and dorsomedial srtiatum in encoding and recovery processes of latent inhibition

      2014, Neurobiology of Learning and Memory
      Citation Excerpt :

      Lidocaine 2% (Sigma Aldrich) was delivered at a rate of 0.25 μl per min for 2 min, with a total volume of 0.5 μl per side. Previous studies in our lab and several works have employed lidocaine successfully with similar doses (Waraczynski, 2003; Woods & Ettenberg, 2004). This volume produces neuronal inhibition for around 30 min, and the spherical boundary surrounding the infusion cannula tip is estimated with a radius of 0.5 mm (Lomber, 1999).

    • Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine

      2012, Neuroscience Letters
      Citation Excerpt :

      AMPHs and other psychostimulants induce profound behavioral activation in rats, mice, and other animals used in the psychopharcological studies, such as increased locomotion, rearing, and sniffing behavior. Locomotor activating effects of AMPH are dependent on the nucleus accumbens [34], although the degree of activity is mediated by regulatory regions outside of the NAc, including the hippocampus [48], the amygdala [49], and the medial prefrontal cortex [20]. An additional element observed in this study was that both m-AMPH and d-AMPH at 2 mg/kg increased the number of visits to the center of the open-field, showing the equivalence of the two drugs to induce risk-taking behavior in rats.

    • Inactivation of the medial preoptic area/anterior hypothalamus by lidocaine reduces male sexual behavior and sexual incentive motivation in male rats

      2008, Neuroscience
      Citation Excerpt :

      Half of the animals were injected with saline (2 μl per cannula) and the other half with lidocaine (40 μg in 2 μl of saline per cannula). This lidocaine dose is within the range usually employed in behavioral studies (Woods and Ettenberg, 2004; Broadbent et al., 2006). At infusions the injector was placed into the guide cannula 5 min before starting drug or saline administration.

    View all citing articles on Scopus
    View full text